G-CSF Prophylaxis in High-Risk Female Patients with solid Tumors in clinical Practice: IMPACT SOLID Study

被引：0
|
作者：
Vavra, C. [1 ,2 ]
Singer, C. [3 ]
Staudigl, C. [3 ]
Hubalek, M. [4 ]
Unterrieder, K.
Jaeger, C. [5 ]
Sevelda, P. [1 ,2 ]
机构：
[1] Krankenhaus Hietzing Neurol Zentrum Rosenhugel, Gynakol Geburtshilfliche Abt, Vienna, Austria
[2] Karl Landsteiner Inst Gynakolog Onkol & Senol, Vienna, Austria
[3] Med Univ Wien, Univ Klin Frauenheilkunde, Vienna, Austria
[4] Med Univ Innsbruck, Univ Klin Frauenheilkunde, Klin Abt Gynakol & Geburtshilfe, Innsbruck, Austria
[5] Amgen GmbH, Vienna, Austria
来源：
GEBURTSHILFE UND FRAUENHEILKUNDE | 2012年 / 72卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] G-CSF AS SECONDARY PROPHYLAXIS OF CHEMOTHERAPY-INDUCED NEUTROPENIA IN PATIENTS WITH SOLID TUMORS: RESULTS OF A PROSPECTIVE, OBSERVATIONAL STUDY
    Freyer, G.
    Jovenin, N.
    Yazbek, G.
    Villanueva, C. B.
    Hussain, A.
    Bethune, A.
    Rotarski, M.
    Simon, H.
    Boulanger, V.
    Hummerlsberger, M.
    ANNALS OF ONCOLOGY, 2012, 23 : 499 - 500
  • [2] A prospective observational study to evaluate G-CSF usage in patients with solid tumors receiving myelosuppressive chemotherapy in Italian clinical oncology practice
    Barni, S.
    Lorusso, V.
    Giordano, M.
    Sogno, G.
    Gamucci, T.
    Santoro, A.
    Passalacqua, R.
    Iaffaioli, V.
    Zilembo, N.
    Mencoboni, M.
    Roselli, M.
    Pappagallo, G.
    Pronzato, P.
    MEDICAL ONCOLOGY, 2014, 31 (01)
  • [3] A prospective observational study to evaluate G-CSF usage in patients with solid tumors receiving myelosuppressive chemotherapy in Italian clinical oncology practice
    S. Barni
    V. Lorusso
    M. Giordano
    G. Sogno
    T. Gamucci
    A. Santoro
    R. Passalacqua
    V. Iaffaioli
    N. Zilembo
    M. Mencoboni
    M. Roselli
    G. Pappagallo
    P. Pronzato
    Medical Oncology, 2014, 31
  • [4] G-CSF use and neutropenic events in patients with breast and lung tumours: data from routine clinical practice (IMPACT Solid study)
    Krzemieniecki, K.
    Erdkamp, F.
    Lindman, H.
    Maenpaa, J.
    Puertas, J.
    Schwenkglenks, M.
    Sevelda, P.
    Smakal, M.
    Varthalitis, I.
    Verma, S.
    EJC SUPPLEMENTS, 2009, 7 (02): : 186 - 186
  • [5] GRANULOCYTE COLONY STIMULATING FACTOR (G-CSF) PROPHYLAXIS AND FEBRILE NEUTROPENIA (FN) INCIDENCE IN PATIENTS WITH SOLID TUMOURS RECEIVING MYELOTOXIC CHEMOTHERAPY WHO ARE ASSESSED AS HIGH RISK FOR FN: IMPACT SOLID STUDY
    Maenpaa, J.
    Sevelda, P.
    Smakal, M.
    Trojan, A.
    Puertas, J.
    Schwenkglenks, M.
    Erdkamp, F. L. G.
    Szabo, Z.
    Bendall, K.
    Krzemieniecki, K.
    ANNALS OF ONCOLOGY, 2010, 21 : 377 - 377
  • [6] Serum G-CSF levels in neutropenia developing after chemotherapy in patients with solid tumors
    Gunel, N
    Uner, A
    Yamac, D
    Akcali, Z
    10TH MEDITERRANEAN CONGRESS OF CHEMOTHERAPY, 1996, : 493 - 497
  • [7] Pharmacokinetic and Pharmacodynamic Characteristics of Tripegfilgrastim, a Pegylated G-CSF, in Pediatric Patients with Solid Tumors
    Lee, Soyoung
    Hong, Kyung Taek
    Moon, Seol Ju
    Choi, Jung Yoon
    Hong, Che Ry
    Shin, Hee Young
    Cho, Joo-Youn
    Jang, In-Jin
    Yu, Kyung-Sang
    Oh, Jaeseong
    Kang, Hyoung Jin
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 (01) : 293 - 301
  • [8] G-CSF/GM-CSF-induced hematopoietic dysregulation in the progression of solid tumors
    He, Kai
    Liu, Xi
    Hoffman, Robert D.
    Shi, Rong-Zhen
    Lv, Gui-Yuan
    Gao, Jian-Li
    FEBS OPEN BIO, 2022, 12 (07): : 1268 - 1285
  • [9] Risk factors for reduced relative dose intensity (RDI) in patients with solid tumors receiving chemotherapy (CT) and primary prolonged G-CSF prophylaxis by empegfilgrastim: Analysis of DEFENDOR study
    Snegovoy, A.
    Kononenko, I. B.
    Sorokina, I.
    Kiseleva, P.
    Mironenko, O.
    Berezina, A.
    Prosianikova, O.
    ANNALS OF ONCOLOGY, 2024, 35 : S1097 - S1098
  • [10] CLINICAL EFFICACY OF PAZOPANIB IN HIGH-RISK PEDIATRIC SOLID TUMORS:A MULTICENTER RETROSPECTIVE STUDY
    Brizini, Meziane
    Naccache, Lamia
    Tibout, Pauline
    Goudie, Catherine
    Budd, Crystal
    Vairy, Stephanie
    Brisson, Marie-Claude
    Tran, Thai Hoa
    Santiago, Raoul
    PEDIATRIC BLOOD & CANCER, 2022, 69
12345